Pharos iBio Co., Ltd. (KOSDAQ:388870)
4,735.00
+365.00 (8.35%)
At close: Jul 31, 2026
-19.61% (1Y)
| Market Cap | 61.30B -19.6% |
| Revenue (ttm) | n/a |
| Net Income | -9.94B |
| EPS | -767.76 |
| Shares Out | 12.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 75,159 |
| Open | 4,310.00 |
| Previous Close | 4,370.00 |
| Day's Range | 4,310.00 - 4,780.00 |
| 52-Week Range | 3,710.00 - 12,120.00 |
| Beta | -0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 31, 2026 |